Clinical trial
Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the…
NCT00003017 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003017 |
|---|---|
| Title | Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix |
| Official title | Phase II Clinical Trial of Interleukin-12 in Patients With Advanced, Recurrent or Inoperable Carcinoma of the Cervix |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Biological |
| Interventions | recombinant interleukin-12 |
| Start date | Jul 1, 1997 |
| Completion | Aug 1, 2005 |
| First posted | Apr 22, 2004 |
| Last update posted | Jun 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: